##  [KAE609](/node/36376 "KAE609") 

  



cipargamin

[In-market Brands and Global Health](/taxonomy/term/11046)

[Phase 2](/taxonomy/term/2881)

[≥ 2029](/taxonomy/term/11576)

[PfATP4 inhibitor](/taxonomy/term/3016)

 

Malaria severe

[Lead Indication](/taxonomy/term/2811)



- [Print](/node/36376/printable/print)
- [PDF](/node/36376/printable/pdf)